TABLE 7-1Structure of Study Centers for a Government-Sponsored Randomized Controlled Trial (Diabetes Prevention Program [DPP]) and an Industry-Sponsored Randomized Controlled Trial (A Diabetes Progression Outcomes Trial [ADOPT])

No. of Countries1 (USA)17 (USA, Canada, Europe)
No. of Centers27488
No. of Subjects3,8194,360
Subjects per Center62–193 (Nat. American: 20–80)1–48
ReimbursementFTE basedVisit based

NOTE: FTE = full-time equivalent.

SOURCE: Kahn, 2009.

From: 7, Clinical Trials in Diabetes

Cover of Transforming Clinical Research in the United States
Transforming Clinical Research in the United States: Challenges and Opportunities: Workshop Summary.
Institute of Medicine (US) Forum on Drug Discovery, Development, and Translation.
Washington (DC): National Academies Press (US); 2010.
Copyright © 2010, National Academy of Sciences.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.